Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection ...
Subcutaneous Weltruza, approved by the FDA in October, provides a new once-monthly treatment option for people with schizophrenia that developers with Teva Pharmaceuticals said offers the same safety ...
Schizophrenia and Dementia Medications Shift to Once-Monthly Injections FDA Approves Tevas Weltruza, Expanding Long-Acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results